AI-Guided Intensified Follow-up After Surgery for Acute Type A Aortic Dissection

NCT07623213 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1314

Last updated 2026-06-03

No results posted yet for this study

Summary

This multicenter, prospective, randomized controlled trial will evaluate whether an artificial intelligence (AI) multimodal prediction model-guided intensified follow-up strategy improves 1-year outcomes after surgery for acute Stanford type A aortic dissection. Eligible adult patients who have undergone open surgical repair or open plus endovascular/hybrid repair and are clinically stable to enter the postoperative follow-up phase will be randomized 1:1 to usual postoperative follow-up or AI-guided intensified follow-up. The AI-guided arm will receive usual follow-up plus an AI-generated risk stratification report for 1-year mortality and adverse aortic remodeling. Higher-risk patients may receive more frequent follow-up, prioritized CTA review, multidisciplinary assessment, and targeted management reminders. The primary outcome is all-cause mortality through postoperative day 365. Key secondary outcomes include aortic reintervention, adverse aortic remodeling, and ICU readmission within 1 year.

Conditions

  • Acute Type A Aortic Dissection
  • Stanford Type A Aortic Dissection
  • Postoperative Aortic Dissection Follow-up

Interventions

OTHER

Usual Postoperative Follow-up Strategy

Routine postoperative surveillance and management after acute type A aortic dissection repair according to each center's standard clinical practice.

OTHER

AI Prediction Model-Guided Intensified Follow-up Strategy

Use of a previously developed AI multimodal prediction model to generate risk stratification for postoperative 1-year mortality and adverse aortic remodeling, triggering protocolized intensified follow-up actions when indicated.

Sponsors & Collaborators

  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    collaborator OTHER
  • Guangdong Provincial People's Hospital

    collaborator OTHER
  • Sir Run Run Shaw Hospital

    collaborator OTHER
  • Wuhan Asia Heart Hospital

    collaborator OTHER
  • Tongji Hospital

    collaborator OTHER
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • Renmin Hospital of Wuhan University

    collaborator OTHER
  • Beijing Anzhen Hospital

    collaborator OTHER
  • Second Affiliated Hospital, Zhejiang University, School of Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-12-01
Primary Completion
2028-12-01
Completion
2029-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07623213 on ClinicalTrials.gov